Role of inositol (1,4,5)trisphosphate in epidermal growth factor- induced Ca2+ signaling in A431 cells

AR Hughes, GS Bird, JF Obie, O Thastrup and JW Putney

Laboratory of Cellular and Molecular Pharmacology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709.

The effects of epidermal growth factor on Ca2+ signaling in A431 cells were investigated. Epidermal growth factor induced a transient Ca2+ signal in the absence of external Ca2+ and a sustained response in the presence of extracellular Ca2+, indicating an ability to mobilize intracellular Ca2+ as well as the ability to increase Ca2+ entry from the extracellular space. The Ca(2+)-ATPase inhibitor thapsigargin also activated Ca2+ entry, and neither epidermal growth factor nor the guanine nucleotide-dependent protein-linked receptor agonist bradykinin activated additional Ca2+ entry over that due to thapsigargin. In nominally Ca(2+)-free medium, the addition of bradykinin to A431 cells rapidly but transiently increased inositol 1,4,5-trisphosphate and, in parallel fashion, transiently increased cytosolic Ca2+. Unexpectedly, under these experimental conditions, epidermal growth factor elicited a small but significant Ca2+ signal after the addition of bradykinin. Experiments were designed to determine whether the Ca2+ response to epidermal growth factor after bradykinin results from mobilization of Ca2+ by an inositol 1,4,5-trisphosphate-independent mechanism. Epidermal growth factor stimulated additional inositol 1,4,5- trisphosphate formation in bradykinin-treated cells. Furthermore, the Ca2+ signals elicited by both bradykinin and epidermal growth factor were blocked in cells microinjected with the inositol 1,4,5- trisphosphate receptor antagonist heparin, whereas the intracellular Ca(2+)-ATPase inhibitor thapsigargin still mobilized Ca2+. Finally, histamine, a less efficacious guanine nucleotide-dependent protein- linked receptor agonist, as well as photolyzed, microinjected, caged inositol 1,4,5-trisphosphate, also mobilized Ca2+ after bradykinin. The results of this study show (i) that epidermal growth factor activates intracellular Ca2+ release as well as Ca2+ entry, the latter most likely resulting from an indirect effect due to the depletion of intracellular Ca2+ pools, (ii) that the actions of epidermal growth factor on Ca2+ homeostasis can be fully accounted for by inositol 1,4,5- trisphosphate formation, and (iii) that the ability of A431 cells to produce Ca2+ signals when epidermal growth factor is applied after bradykinin can be explained by the rapid and complete desensitization of the bradykinin stimulated phospholipase C activity.

Volume 40, Issue 2, pp. 254-262, 08/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				P. Sengupta, M. J. Ruano, F. Tebar, U. Golebiewska, I. Zaitseva, C. Enrich, S. McLaughlin, and A. Villalobo Membrane-permeable Calmodulin Inhibitors (e.g. W-7/W-13) Bind to Membranes, Changing the Electrostatic Surface Potential: DUAL EFFECT OF W-13 ON EPIDERMAL GROWTH FACTOR RECEPTOR ACTIVATION J. Biol. Chem., March 16, 2007; 282(11): 8474 - 8486. [Abstract] [Full Text] [PDF]

				S. McLaughlin, S. O. Smith, M. J. Hayman, and D. Murray An Electrostatic Engine Model for Autoinhibition and Activation of the Epidermal Growth Factor Receptor (EGFR/ErbB) Family J. Gen. Physiol., June 27, 2005; 126(1): 41 - 53. [Abstract] [Full Text] [PDF]

				M. Koltzscher, C. Neumann, S. Konig, and V. Gerke Ca2+-dependent Binding and Activation of Dormant Ezrin by Dimeric S100P Mol. Biol. Cell, June 1, 2003; 14(6): 2372 - 2384. [Abstract] [Full Text] [PDF]

				B.-X. Zhang, C.-K. Yeh, T. K. Hymer, M. D. Lifschitz, and M. S. Katz EGF inhibits muscarinic receptor-mediated calcium signaling in a human salivary cell line Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1024 - C1033. [Abstract] [Full Text] [PDF]

				M.-S. Huang, O. A. Adebanjo, E. Awumey, G. Biswas, A. Koval, B. R. Sodam, L. Sun, B. S. Moonga, J. Epstein, S. Goldstein, et al. IP3, IP3 receptor, and cellular senescence Am J Physiol Renal Physiol, April 1, 2000; 278(4): F576 - F584. [Abstract] [Full Text] [PDF]

				R. S. Mathias, K. Mikoshiba, T. Michikawa, A. Miyawaki, and H. E. Ives IP3 receptor blockade fails to prevent intracellular Ca2+ release by ET-1 and alpha -thrombin Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1456 - C1465. [Abstract] [Full Text] [PDF]

				S. P. Soltoff and A. Toker Carbachol, Substance P, and Phorbol Ester Promote the Tyrosine Phosphorylation of Protein Kinase C[IMAGE] in Salivary Gland Epithelial Cells J. Biol. Chem., June 2, 1995; 270(22): 13490 - 13495. [Abstract] [Full Text] [PDF]